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During 2005, 764 children were brought to a large chil-
dren’s hospital in Ho Chi Minh City, Vietnam, with a diagno-
sis of hand, foot, and mouth disease. All enrolled children 
had specimens (vesicle ﬂ  uid, stool, throat swab) collected 
for enterovirus isolation by cell culture. An enterovirus was 
isolated from 411 (53.8%) of the specimens: 173 (42.1%) 
isolates were identiﬁ  ed as human enterovirus 71 (HEV71) 
and 214 (52.1%) as coxsackievirus A16. Of the identiﬁ  ed 
HEV71 infections, 51 (29.5%) were complicated by acute 
neurologic disease and 3 (1.7%) were fatal. HEV71 was iso-
lated throughout the year, with a period of higher prevalence 
in October–November. Phylogenetic analysis of 23 HEV71 
isolates showed that during the ﬁ  rst half of 2005, viruses 
belonging to 3 subgenogroups, C1, C4, and a previously 
undescribed subgenogroup, C5, cocirculated in southern 
Vietnam. In the second half of the year, viruses belonging to 
subgenogroup C5 predominated during a period of higher 
HEV71 activity.
H
and, foot, and mouth disease (HFMD) is a common 
febrile illness of early childhood, characterized by 3–4 
days of fever and the development of a vesicular enanthem 
on the buccal mucosa, gums, and palate and a papulovesic-
ular exanthem on the hands, feet, and buttocks (1). HFMD 
is caused by acute enterovirus infections, particularly by 
viruses belonging to the human enterovirus A (HEVA)   
species (1).
The genus Enterovirus of the family Picornaviridae 
is divided into 9 species, 5 of which infect humans. These 
viruses include the prototype species poliovirus, as well as 
HEVA, HEVB, HEVC, and HEVD. Viruses belonging to 
the HEVA species include 11 serotypes of coxsackievirus 
A (CVA; serotypes 2–8, 10, 12, 14, and 16), and human 
enterovirus 71 (HEV71) (2,3).
Although all HEVA viruses can cause HFMD, infec-
tion with HEV71 is also associated with a high prevalence 
of acute neurologic disease (4). Despite their close genetic 
relationship to HEV71, the HEVA CVA viruses rarely 
cause acute neurologic disease. HEV71 infection is associ-
ated with a wide spectrum of acute central nervous system 
syndromes, including aseptic meningitis, poliomyelitis-
like paralysis, brainstem encephalitis, and acute neurogenic 
pulmonary edema (4). Children <5 years of age are par-
ticularly susceptible to HEV71-associated acute neurologic 
disease, which may occasionally cause permanent neuro-
logic disability or death (4).
Since the discovery of HEV71 in 1969 (5), numerous 
outbreaks of this infection have occurred throughout the 
world (4). The prevalence of HEV71 infection in the Asia-
Paciﬁ  c region has greatly increased since 1997, concurrent 
with an increase in the prevalence of HFMD and acute neu-
rologic disease (6–11). Outbreaks have been recorded in 
Japan (12), Malaysia (7), Singapore (4), South Korea (6), 
the People’s Republic of China (13), and Australia (14–16). 
The most extensive epidemic of HEV71 occurred in Tai-
wan in 1998, with ≈1.3 × 105 cases of HFMD, 405 cases of 
severe neurologic disease, and 78 deaths. The deaths were 
due primarily to the development of brainstem encephalitis 
and neurogenic pulmonary edema (8,17).
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Before 1999, most cases of encephalitis in southern 
Vietnam occurred in children >5 years of age, of which 
≈60% were identiﬁ  ed as Japanese encephalitis (diagnostic 
records of the Pasteur Institute, Ho Chi Minh City, Viet-
nam). Since 2002, however, viral encephalitis has increas-
ingly been observed in younger children, particularly in 
those <4 years. Furthermore, since 2002 <27% of encepha-
litis cases have been conﬁ  rmed as Japanese encephalitis, 
which indicates that the epidemiology of viral encephalitis 
in southern Vietnam may be changing. This situation led us 
to consider other possible causes for viral encephalitis.
In 2003, we isolated HEV71 (at the Pasteur Institute, 
Ho Chi Minh City, Vietnam) from 12 patients with en-
cephalitis, who sought treatment at the hospital during an 
HFMD outbreak in southern Vietnam. To our knowledge, 
this was the ﬁ  rst identiﬁ  cation of HEV71 in Vietnam. Al-
though laboratory surveillance has been shown to provide 
adequate warning of impending outbreaks of HEV71-as-
sociated acute neurologic disease (18), laboratory surveil-
lance for HEV71 has not yet been established in Vietnam. 
Materials and Methods
Study Participants and Specimen Collection
Children <15 years of age were admitted to a large pe-
diatric hospital in Ho Chi Minh City, Vietnam. This hos-
pital serves ≈70% of the city’s pediatric population; 764 
children with HFMD were enrolled in the study. HFMD 
was deﬁ  ned as a febrile illness (>37.5°C), accompanied by 
a papulovesicular rash in a characteristic distribution (oral 
mucosa, extremities of limbs, buttocks). A total of 1,928 
specimens were collected from the children on the day of 
admission. Each child had at least 1 specimen collected 
from vesicle ﬂ  uid, throat swab, or stool. Children who also 
exhibited acute neurologic disease had a cerebrospinal ﬂ  u-
id specimen collected. All specimens were extracted with 
chloroform (1:10 in phosphate-buffered saline) before vi-
rus isolation in cell culture.
Virus Isolation
Virus isolation was undertaken in cell culture by using 
both human rhabdomyosarcoma (RD) (ATCC CCL136) and 
African green monkey kidney (Vero) (ATCC CCL81) cell 
lines. Each specimen underwent at least 2 cell culture pas-
sages in RD and Vero cells before being reported as negative. 
Samples demonstrating viral cytopathic effect (CPE) were 
screened for enterovirus RNA by reverse transcription–PCR 
(RT-PCR), as outlined in the following section.
RNA Extraction from Cell Culture Supernatants
Total cellular RNA was extracted from cell culture su-
pernatants that demonstrated CPE; Tri-reagent (Ambion, 
Austin, TX, USA) was used. The RNA obtained from 250 
μL of infected cell culture supernatant was suspended in 30 
μL RNase-free water and stored at –80°C before use.
Enterovirus Screening Assays 
Cell cultures showing CPE were screened for entero-
virus RNA. Two “pan enterovirus” and 1 HEV71-speciﬁ  c 
RT-PCR assays were used, as described (19–22). 
Pan Enterovirus RT-PCR Assay, 
5′ Untranslated Region (UTR)
Brieﬂ  y, cDNA was prepared in a 10-μL reaction mix-
ture containing 6 μL RNA template, 0.5 mmol/L dNTP, 200 
U Moloney murine leukemia virus reverse transcriptase (M-
MuLV RT) (Promega, Madison WI, USA), and M-MuLV 
RT buffer (Promega). cDNA synthesis was performed for 1 h 
at 42°C. In the PCR step, the 5′UTR was ampliﬁ  ed by using 
2 μL of cDNA in a 20-μL reaction volume, as described by 
Romero and Rotbart (19). The PCR products were examined 
by gel electrophoresis. Oligonucleotide primers for this assay 
(forward primer MD90, reverse primer MD91) ﬂ  ank a con-
served nucleotide sequence in the 5′UTR of the enterovirus 
genome and amplify an expected product size of 154 bp.
Pan Enterovirus RT-PCR Assay, VP4
Enterovirus VP4 gene RT-PCR was performed by us-
ing primers OL68–1 and MD91, as described (20). Brieﬂ  y, 
cDNA was prepared from a 10-μL reaction mixture con-
taining 5.5 μL RNA, 0.5 mmol/L dNTP, 200 U M-MuLV 
RT (Fermentas, Burlington, Ontario, Canada), M-MuLV 
RT buffer (Fermentas), and the antisense primer OL68-1. 
cDNA synthesis was performed for 1 h at 37°C. In the PCR 
step, the VP4 gene was ampliﬁ  ed by using 2 μL of cDNA 
in a 20-μL reaction volume with previously described cy-
cling conditions (20).
HEV71-speciﬁ  c RT-PCR Assay
The HEV71-speciﬁ  c RT-PCR was performed as de-
scribed (21,22) to provide rapid identiﬁ  cation of HEV71 in 
cell culture supernatants that were positive in the screening 
RT-PCR assay. First, strand cDNA was prepared as out-
lined above. In the PCR step, the VP1 gene was ampliﬁ  ed 
by using 2 μL of cDNA in a 20-μL reaction volume, as 
described (22). The PCR products were examined by gel 
electrophoresis. Oligonucleotide primers for this assay 
(forward primer MAS01S, reverse primer MAS02A) ﬂ  ank 
a region within the VP1 gene unique to HEV71 and am-
plify an expected product size of 376 bp.
RT-PCR for Conﬁ  rmation and Sequencing
HEV71 Complete VP1 RT-PCR Assay
The VP1 gene of 23 HEV71 strains isolated in this 
study was ampliﬁ  ed by RT-PCR by using in-house oli-
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gonucleotide primers that ﬂ  ank the entire VP1 gene re-
gion, HEV71-VP1-F2 (5′-ATAATAGCAYTRGCG
GCAGCCCA-3′; forward) and HEV71-VP1-R1 (5′-TGR
GCRGTGGTAGAYGAYAC-3′; reverse). First-strand 
cDNA synthesis was performed as above, except the reac-
tion was primed with HEV71-VP1-R1. For the PCR step, 
2 μL of ﬁ  rst-strand cDNA was added to a 50-μL reaction 
volume containing 1.5 mmol/L MgCl2, 1 mmol/L each of 
primers HEV71-VP1-F2 and HEV71-VP1-R1, 0.3 mM 
dNTP, 2.5 U Taq DNA polymerase (Fermentas), and Taq 
polymerase buffer (Fermentas). PCR cycling conditions 
included an initial denaturation step at 94°C for 5 min, fol-
lowed by 35 cycles of 94°C for 20 s, 55°C for 30 s, and 
72°C for 1 min. This cycling was followed by a ﬁ  nal ex-
tension at 72°C for 5 min. PCR products (≈1.1 kb) were 
examined by gel electrophoresis and puriﬁ  ed by using the 
GENECLEAN III kit (Qbiogene, Irvine, CA, USA).
Partial VP1 RT-PCR Assay
To identify HEV viruses that were not detected by 
the VP4 RT-PCR screening assay, a molecular serotyping 
method based on RT-PCR ampliﬁ  cation and sequencing of 
a portion of the VP1 gene was performed as described (23). 
An ≈340-bp fragment was ampliﬁ  ed by RT-PCR by using 
the forward primer 292 (5′-MIGCIGYIGARACNGG-3′) 
and reverse primer 222 (5′-CICCIGGIGGIAYRWACAT-
3′), under conditions exactly as described by Oberste et al. 
(23). PCR products were examined by gel electrophoresis 
and puriﬁ   ed by using the GENECLEAN III kit (Qbio-
gene).
Nucleotide Sequencing of HEV71 VP4 and VP1 Gene 
Amplicons
Enterovirus VP4 gene amplicons were sequenced on 
both strands by using the PCR primers. HEV71 VP1 gene 
amplicons were sequenced on both strands by using the 
PCR primers and internal VP1 primers 161 and 162, de-
scribed by Brown et al. (24). Sequencing was performed by 
using the Big Dye Cycle Sequencing kit version 3.0 and an 
ABI377 automated DNA sequencer (Applied Biosystems, 
Foster City, CA, USA). The SeqMan software module in 
the Lasergene suite of programs (DNASTAR, Madison, 
WI, USA) was used to format the nucleotide sequences. 
Partial VP1 and VP4 sequences for 173 HEV71 strains and 
214 CVA16 strains have been submitted to the European 
Molecular Biology Laboratory database (partial VP1 gene 
accession nos. EU072122-EU072195; VP4 gene accession 
nos. EU051005-EU051317).
HEV71 VP1 Gene Nucleotide 
Sequence Data from GenBank
In addition to 23 VP1 gene sequences from HEV71 
strains isolated in Vietnam, 26 VP1 gene nucleotide se-
quences of HEV71 strains available in the GenBank data-
base were included in this analysis, allowing the generation 
of a dendrogram containing 49 strains isolated between 
1970 and 2005 (Table 1). The strains used to reproduce the 
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Table 1. HEV71 VP1 gene nucleotide sequences used in 
reconstruction of the HEV71 dendrograms* 
Isolate Source
GenBank
accession no.
CVA16-G10 GenBank NC_001612
BrCr-CA/USA/70 GenBank U22521
shzh02–62 GenBank AY895136
shzh04–12 GenBank AY895144
shzh01–3 GenBank AY895132
shzh04–3 GenBank AY895142
shzh01–4 GenBank AY895134
SB12007-SAR-03 GenBank AY905548
SB12282-SAR-03 GenBank AY905546
SB9465-SAR-03 GenBank AY258302
SB9508-SAR-03 GenBank AY258301
S10822/SAR/98 GenBank AF376079
2037-MD/USA/95 GenBank AF009556
S18191/SAR/02 GenBank AY189154
1M/AUS/12/00 GenBank AF376098
13/KOR/00 GenBank AY125976
06/KOR/00 GenBank AY125970
8M/AUS/6//99 GenBank AF376109
1245a/TWN/98 GenBank AF176044
3799/SIN/98 GenBank AF376117
MY104–9/SAR/97 GenBank AF376072
2027/SIN/01 GenBank AF376111
SB2864/SAR/00 GenBank AF376066
8102-WA/USA/87 GenBank AF009526
7423-MS/USA/87 GenBank U22522
2229-NY/USA/76 GenBank AF135868
1011-ND/USA/79 GenBank AF135864
1001V/VNM/05 This study  AM490141
1089T/VNM/05 This study  AM490142
1091S/VNM/05 This study AM490143
1129V/VNM/05 This study  AM490144
1135T/VNM/05 This study  AM490145
1177T/VNM/05 This study  AM490146
1192S/VNM/05 This study  AM490147
1277S/VNM/05 This study  AM490148
1301V/VNM/05 This study  AM490149
1303S/VNM/05 This study  AM490150
540V/VNM/05 This study  AM490151
559S/VNM/05 This study  AM490152
666T/VNM/05 This study  AM490153
707V/VNM/05 This study  AM490154
718T/VNM/05 This study  AM490155
730T/VNM/05 This study  AM490156
777T/VNM/05 This study  AM490157
784S/VNM/05 This study  AM490158
900S/VNM/05 This study  AM490159
926V/VNM/05 This study  AM490160
933V/VNM/05 This study  AM490161
962T/VNM/05 This study  AM490162
999T/VNM/05 This study  AM490163
*HEV71, human enterovirus 71; CVA16, coxsackievirus A16. RESEARCH
HEV71 tripartite genogroup structure identiﬁ  ed by Brown 
et al. (24) were isolated in the United States, Japan, Austra-
lia, Malaysia, Singapore, Taiwan, the People’s Republic of 
China, Hungary, South Korea, and the United Kingdom.
Phylogenetic Analysis
VP1 and VP4 gene sequences were subjected to nu-
cleotide-nucleotide BLAST analysis (blastn) by using the 
online server at the National Center for Biotechnology In-
formation (www.ncbi.nlm.nih.gov/blast). Alignment of the 
23 HEV71 complete VP1 gene sequences was undertaken 
by using the ClustalW program (25). A dendrogram was 
constructed by using the neighbor-joining method with 
PHYLIP version 3.5 (26) and drawn by using TreeView 
(27). Bootstrap analysis with 1,000 pseudoreplicates was 
performed by using the program Seqboot (28). Coxsacki-
evirus A16 (CVA16), strain G10 (29), was used as an out-
group in the analysis.
Statistical Methods
Differences between proportions were tested by using 
the χ2 test with Yates correction or Fisher exact test. Epi 
Info version 6 (Centers for Disease Control and Prevention, 
Atlanta, GA, USA) was used for the analysis.
Results
Virus Isolation from HFMD Patients
An enterovirus was isolated from 411 (53.8%) of the 
764 HFMD patients enrolled in the study. The number of 
CVA16, HEV71, and other enterovirus serotypes isolated 
from HFMD patients is presented in Table 2. CVA16 was 
identiﬁ  ed in 214 (52.1%) and HEV71 in 173 (42.1%) of the 
enterovirus-positive HFMD patients. Twenty-four (5.8%) 
enteroviruses of another serotype were also isolated from 
HFMD patients (Table 2).
Procedures for the isolation and identiﬁ  cation of en-
terovirus strains obtained in the study are presented in a 
ﬂ  owchart (Figure 1). Of the 411 enteroviruses isolated in 
this study, 170 were identiﬁ  ed by using HEV71-speciﬁ  c 
primers. Another 3 were identiﬁ  ed as HEV71 when the VP4 
and partial VP1 RT-PCR products were sequenced. We 
used the RT-PCR assay and sequencing of the VP4 gene as 
a screening tool because a single set of primers allowed us 
to obtain a preliminary identiﬁ  cation of HEV71 or CVA16. 
In our laboratory, 256 enterovirus isolates were sequenced 
in both VP1 and VP4, and 100% concordance was found 
between the VP1 and VP4 results for HEV71 (130 isolates) 
and CVA16 (61 isolates); only 28 (43%) of 65 other entero-
viruses had concordant results in both the VP1 and VP4 se-
quences (unpub. data). Thus, 24 non-HEV71, non-CVA16 
isolates were identiﬁ  ed as other enteroviruses.
Clinical Features of HFMD
The clinical features observed in HFMD patients en-
rolled in the study are presented in Figure 2, panel A. By 
deﬁ  nition, children enrolled in the study all displayed the 
characteristic papulovesicular rash of HFMD; 214 cases 
of HFMD were associated with CVA16 infection, and 173 
cases were associated with HEV71 infection. Notably, the 
formation of ulcers on the oral cavity was observed less fre-
quently with HEV71 infection than CVA16 infection (102 
[58.9%] of 173 HEV71 patients vs.178 of 214 CVA16 pa-
tients [83.2%]; p<0.0001, odds ratio [OR] 0.29, 95% con-
ﬁ  dence interval [CI] 0.18–0.48). Cough was also observed 
more frequently with HEV71 infection than CVA16 infec-
tion (70 of 173 [40.5%] vs. 59 [27.6%] of 214; OR 1.79, 
95% CI 1.14–2.8). Altered sensorium was experienced by 
10 (5.8%) of the 173 HEV71 patients and, as expected, by 
none of the CVA16 patients. This ﬁ  nding was signiﬁ  cant 
(p = 0.0003), but due to the small numbers, the OR could 
not be calculated.
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Table 2. Total number of enterovirus serotypes isolated from 
hand, foot, and mouth disease cases, southern Vietnam, 2005 
Virus serotype*  No. cases 
CVA16 214
HEV71 173
Other enterovirus 24
Negative 352
Total 763
*CVA16, coxsackievirus A16; HEV71, human enterovirus 71. 
Figure 1. Flowchart showing the procedures used for isolating and 
identifying enterovirus strains cultured from clinical specimens 
obtained from children admitted to a large pediatric hospital in 
Ho Chi Minh City, Vietnam, with a diagnosis of hand, foot, and 
mouth disease (HFMD) during 2005 and enrolled in this study. 
EV, enterovirus; RT-PCR, reverse transcription–PCR; 5′ UTR, 5′ 
untranslated region; HEV71, human enterovirus 71. Hand, Foot, and Mouth Disease, Vietnam
Clinical signs of neurologic infection were observed 
primarily with HEV71-associated HFMD. Convulsions 
were observed for 18 (10.4%) of 173 HEV71 patients and 
4 of 214 (1.9%) CVA16 patients, respectively (p = 0.0007, 
OR 6.10, 95% CI 1.95–25.15). Vomiting was also signiﬁ  -
cantly more frequent for HEV71 patients (63 [36.4%] of 
173) than for CVA16 patients (30 [14.0%] of 214; p value 
<0.0001, OR 3.51, 95% CI 2.08–5.94). Only patients with 
HEV71-associated HFMD had alteration of consciousness 
(10 [5.8%] of 173, p = 0.0003) or limb weakness (3 of 
173 [1.7%]). In all, acute neurologic disease accounted for 
29.5% (51/173) of identiﬁ  ed cases of HEV71-associated 
HFMD. The case-fatality rate for HEV71-associated acute 
neurologic disease was 5.9% (3/51) and for all HEV71-
associated HFMD was 1.7% (3/173). No fatal cases of 
CVA16-associated HFMD were identiﬁ  ed.
Other clinical signs and symptoms did not differ sig-
niﬁ  cantly between HEV71 and CVA16 patients. Sore throat 
(43.1% of HEV71 patients and 38.7% of CVA16 patients) 
and runny nose (41.8% of HEV71 patients and 42.9% of 
CVA16 patients) were observed in approximately half of 
the HFMD patients. A smaller number of HFMD patients 
exhibited symptoms of gastrointestinal disorder, such as 
diarrhea (9.0% of HEV71 patients and 8.2% of CVA16 
patients). Myalgia (4.7% of HEV71 patients and 5.5% of 
CVA16 patients) and headache (4.5% of HEV71 and 3.4% 
of CVA16 patients) were less common symptoms.
The HFMD cases observed in southern Vietnam oc-
curred primarily in children <5 years of age (Figure 2, 
panel B). Most HEV71 (136/173 patients) and CVA16 
(171/214 patients, 79.9%) infections were identiﬁ  ed  in 
children <3 years of age; the peak age-speciﬁ  c incidence 
of HEV71 (71/173 patients, 40.5%) and CVA16 (94/214 
patients [43.9%) infections were identiﬁ  ed in children 1–2 
years of age.
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Figure 2. Clinical features of hand, foot, and mouth disease 
(HFMD) in children admitted to hospital in southern Vietnam during 
2005. Features were associated with the isolation of coxsackievirus 
A16 (CVA16) (214 cases) or human enterovirus 71 (HEV71) (173 
cases) from vesicle, throat swab, or stool specimens. A) Percentage 
distribution of clinical signs and symptoms among identiﬁ  ed cases 
of HFMD. B) Percentage age distribution of patients with identiﬁ  ed 
cases of HFMD. 
Figure 3. Monthly distribution of 387 cases of hand, foot, and mouth 
disease (HFMD) associated with isolation of either coxsackievirus 
A16 (CVA16) (214 cases) or human enterovirus 71 (HEV71) (173 
cases), southern Vietnam, 2005. RNA was extracted from cells 
inoculated with vesicle, throat swab, or stool specimens. Partial 
VP4 gene sequences were ampliﬁ   ed by reverse transcription–
PCR (RT-PCR) by using speciﬁ   c primers (22), the ampliﬁ  ed 
cDNA sequenced, and the serotype and/or genogroup speciﬁ  city 
determined by BLAST analysis. A) Monthly distribution of CVA16 
and HEV71-associated HFMD cases. B) Monthly distribution of 
173 HFMD cases associated with HEV71 infection with strains 
belonging to subgenogroups C1, C4, or C5.RESEARCH
Epidemiology of HFMD
The distribution of CVA16- and HEV71-associated 
HFMD cases by month during 2005 is presented in Fig-
ure 3, panel A. HFMD was identiﬁ  ed in southern Vietnam 
throughout the year; HEV71 and CVA16 were also isolated 
throughout the year. Two peaks of HFMD activity were 
observed during 2005. The ﬁ  rst peak occurred from March 
through May. CVA16 was the predominant virus during 
this time, accounting for 81.1% (116 cases) of HFMD com-
pared to 18.9% (27 cases) for HEV71 (Figure 2, panel A). 
The second peak of HFMD activity occurred from Sep-
tember through December. HEV71 was the predominant 
virus during this time, accounting for 65.3% (128 cases) of 
HFMD compared to 34.7% (68 cases) for CVA16 (Figure 
3, panel A).
Figure 4 depicts the geographic distribution of HFMD 
cases due to HEV71 (Figure 4, panel A) and CVA16 (Fig-
ure 4, panel B) who were brought for treatment to a major 
children’s hospital in Ho Chi Minh City. Children admitted 
to this hospital are predominantly drawn from the urban 
area but were also referred from provinces surrounding Ho 
Chi Minh City.
Molecular Epidemiology of HEV71
The HEV71 isolates were further analyzed to de-
termine the monthly distribution of viral subgenogroups 
in southern Vietnam during 2005 (Figure 3, panel B). 
This analysis was achieved by RT-PCR ampliﬁ  cation of 
complete VP4 and partial VP1 gene sequences, nucleo-
tide sequencing, and BLAST analysis (20). Using these 
methods, we identiﬁ  ed 3 HEV71 subgenogroups, C1, C4, 
and a previously undescribed subgenogroup, C5. Two vi-
rus isolates (1.2%) belonging to subgenogroup C1 were 
identiﬁ  ed, 1 each in May and June. A total of 9 (5.2%) 
subgenogroup C4 strains were identiﬁ  ed; 7 were isolated 
from March through May and 1 each in October and No-
vember. Strains belonging to the new subgenogroup C5 
(162 [93.6%]/173) were the predominant genetic lineage 
identiﬁ   ed in southern Vietnam during 2005. Subgeno-
group C5 viruses were identiﬁ  ed in each month and were 
the primary cause of the large increase in HFMD from 
September through December.
Because we had identiﬁ  ed a putative new subgeno-
group of HEV71 (C5) by analysis of complete VP4 and par-
tial VP1 gene sequences (Figure 3, panel B), we conducted 
further nucleotide sequence analysis of the complete VP1 
gene of 23 HEV71 isolates whose VP4 sequences were rep-
resentative of all clusters observed in dendrograms gener-
ated from the screening data (9,24). Complete VP1 gene 
sequence analysis is considered the most rigorous method 
for determining the molecular phylogeny of HEV71 strains 
(6,24), and our analysis needed to be conﬁ  rmed with a 
subset of all the isolates (Figure 5). We used previously 
published VP1 gene cDNA sequences to reconstruct the 
subgenogroup lineage structure of HEV71, ﬁ  rst identiﬁ  ed 
by Brown et al. (24) (Table 2).
Two of the Vietnamese HEV71 isolates clustered 
within subgenogroup C1; 5, within subgenogroup C4; and 
16, within the new subgenogroup C5 (Figure 5). The sub-
genogroup clustering of the HEV71 Vietnamese isolates is 
strongly supported by bootstrap analysis, which indicates 
that 3 independent genetic HEV71 lineages (C1, C4, and 
C5) circulated in southern Vietnam during 2005. This, to-
gether with the year-round isolation of CVA16 and HEV71 
from HFMD patients (Figure 3, panels A, B), suggests that 
both viruses circulate endemically in southern Vietnam.
A comparison of the percentage identity of the com-
plete VP1 gene nucleotide sequences of HEV71 subgeno-
group C1–4 viruses with that of 16 Vietnamese subgeno-
group C5 strains is presented in Table 3. Viruses belonging 
to subgenogroup C5 shared 89.1%–91.0%, 88.8%–90.1%, 
88.8%–89.8%, and 87.7%–90.2% similarity to viruses be-
longing to subgenogroups C1, C2, C3, and C4, respective-
ly. The consistent 9%–12.3% difference in nucleotide se-
quence identity between putative subgenogroup C5 strains 
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Figure 4. Geographic distribution of hand, foot, and mouth disease 
cases associated with human enterovirus 71 (A) or coxsackievirus 
A16 (B) infection, southern Vietnam, 2005. Hand, Foot, and Mouth Disease, Vietnam
and those belonging to subgenogroups C1–C4 provides 
strong evidence for the classiﬁ  cation of C5 as a new and 
separate subgenogroup of HEV71.
Discussion
To our knowledge, this study provides the ﬁ  rst com-
prehensive epidemiologic and virologic survey of HFMD, 
CVA16, and HEV71 infection in Vietnam. Similar to the 
situation in other countries, HEV71 infection was associ-
ated with a subset of HFMD cases in which acute neuro-
logic disease developed. Our epidemiologic and phyloge-
netic data suggest that both CVA16 and HEV71 circulate 
endemically in southern Vietnam.
Nearly one third of the HEV71-associated HFMD 
cases identiﬁ  ed in our study were complicated by acute 
neurologic disease. The case-fatality rates of 1.7% in all 
identiﬁ  ed HEV71 infections and 5.9% in HEV71 acute 
neurologic disease cases are higher than those observed 
in other studies (7,30,31). However, the case-fatality rates 
calculated in our study may overestimate the true values 
because only HFMD patients who were brought for treat-
ment at a major children’s hospital were included in the 
study. The best estimates of case-fatality rates for HEV71 
infection have come from a large seroepidemiologic study 
of the 1998 HFMD epidemic in Taiwan (32); the authors 
estimated a case-fatality rate of 96.96 per 100,000 popula-
tion in infants <1 year of age, declining to 6.64 per 100,000 
population in children >5 years of age. To rigorously deter-
mine the incidence and case-fatality rate of HEV71 infec-
tion in southern Vietnam, a similar population-based sero-
epidemiologic study should be undertaken.
Although cases of HFMD were identiﬁ  ed throughout 
the year, 2 periods of increased prevalence were identi-
ﬁ   ed—from March through May and from September 
through December. In southern Vietnam, these months are 
interim periods between the dry and wet seasons. CVA16 
was the predominant virus isolated in the ﬁ  rst period, and 
HEV71 infection was the predominant virus isolated in the 
second period. Ongoing epidemiologic surveillance will be 
necessary to determine whether this pattern of HFMD and 
enterovirus activity recurs in a regular annual cycle.
Phylogenetic analysis based on nucleotide sequence 
alignment of the complete VP1 gene of 23 representative 
strains of HEV71 from southern Vietnam showed that they 
belonged to 3 subgenogroups, C1, C4, and to the previous-
ly undescribed subgenogroup C5. Since 1997, 2 genetically 
distinct major lineages (B, C) of HEV71 have circulated 
in different parts of the Asia-Paciﬁ  c region (6,9). Viruses 
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Table 3. Percentage identity of complete VP1 gene nucleotide sequences of HEV71 genogroup C viruses*
% Nucleotide identity 
Subgenogroup  C1 C2 C3 C4 C5
C1 – 88.4–90.9 89.7–91.2 87.3–91.9 89.1–91.0
C2 – 90.2–91.4 88.7–91.0 88.8–90.1
C3 – 89.3–90.3 88.8–89.8
C4 – 87.7–90.2
C5 –
*HEV71, human enterovirus 71. 
Figure 5. Dendrogram constructed by using the neighbor-joining 
method (25) showing the genetic relationships between 23 human 
enterovirus 71 (HEV71) strains isolated in southern Vietnam 
during 2005 (underlined), based on the alignment of complete 
VP1 gene sequences. Branch lengths are proportional to the 
number of nucleotide differences. The bootstrap values in 1,000 
pseudoreplicates for major lineages within the tree are shown 
as percentages. The marker denotes a measurement of relative 
phylogenetic distance. Strain names indicate a unique numerical 
abbreviation of country and year of isolation. Asterisks (*) 
denote HEV71 isolates obtained from fatal cases. The prototype 
coxsackievirus 16 (CVA16)–G10 strain (28) was used as an 
outgroup. The dendrogram shows genogroups A, B, and C as 
identiﬁ  ed by Brown et al. (24). Details of the strains used to prepare 
the dendrogram are shown in Table 1.RESEARCH
belonging to genogroup B have predominated in South-
east Asia, whereas viruses belonging to genogroup C have 
predominated in northern Asia (6,9,11,33). Before 1997, 
HEV71 strains belonging to subgenogroup C1 were identi-
ﬁ  ed in several small outbreaks around the world (15,24). 
Since 1997, subgenogroup C1 viruses have circulated en-
demically in the Asia-Paciﬁ  c region and have been found 
to cocirculate as a minor subgenogroup together with a 
predominant HEV71 subgenogroup during several out-
breaks (6,11,34). In this study, subgenogroup C1 viruses 
comprised only 1.1% of HEV71 strains isolated, indicating 
low-level circulation. Viruses belonging to subgenogroup 
C2 have circulated widely in the Asia-Paciﬁ  c region be-
tween 1998 and 2000 (9,11,16) and were responsible for 
the large outbreak in Taiwan in 1998 (6,8,9,33). Two new 
genetic lineages of genogroup C, subgenogroups C3 and 
C4, have emerged recently in northern Asia. Viruses be-
longing to subgenogroup C3 ﬁ  rst appeared in the People’s 
Republic of China in 1998 (6) and reemerged in South Ko-
rea in 2000 (6,9). Viruses belonging to subgenogroup C4 
were ﬁ  rst identiﬁ  ed in the People’s Republic of China in 
1998 and again in 2000 (35) before their identiﬁ  cation in 
southern Vietnam during 2005. Furthermore, a new sub-
genogroup, C5, circulated widely in southern Vietnam 
throughout 2005 and became the predominant virus strain 
identiﬁ  ed during the second half of the year.
Our data indicate that the molecular epidemiology of 
HEV71 in southern Vietnam conforms to the northern Asian 
epidemiologic pattern of endemic circulation of genogroup 
C virus strains, with evidence of the ongoing evolution of 
new subgenogroups, similar to that observed for genogroup 
B HEV71 strains in Southeast Asia (6,9,33). Furthermore, 
the year-round isolation and circulation of multiple inde-
pendent genetic lineages of HEV71 (36) suggest that this 
virus circulates endemically within the human population 
of southern Vietnam.
In conclusion, this study has established that HEV71 
circulates endemically in southern Vietnam and thus rep-
resents a substantial threat to the health of children in this 
region. Improvements in public sanitation and personal 
hygiene alone are unlikely to prevent HEV71 transmission 
within the community. A vaccine is necessary to prevent 
HEV71-induced neurologic disease in susceptible children. 
However, until such a vaccine is available, virus activity in 
the community must be monitored through the establish-
ment and maintenance of sentinel surveillance.
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